Opportunities
Search

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups.

Applicant type: Company.

Deadline: Nov 15, 2027.

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Unknown.

Deadline is unknown; verify on the official source.

U.S. Embassy Praia welcomes the submission of project applications for funding through the Ambassador’s Special Self-Help Program (SSH). If interested, please carefully review the instructions below. The SSH is a grass-roots grant assistance program that allows U.S. Ambassadors to support local requests for small community-based development projects. The purpose of the Special Self-Help Program is to support communities through modest grants that will positively impact local communities. The SSH philosophy is to help communities help themselves. Projects submitted for SSH must align with one or more U.S. Embassy priorities:  Economic diversification, including small business creation and income generation  Projects must aim to 1) generate sustainable income and employment opportunities in local communities, 2) advance economic diversification and encourage use of local natural resources or income generation, 3) promote a culture of entrepreneurship, and/or 4) improve economic or living conditions of a community. Women start-ups and women entrepreneurs Eligible projects assist women who are launching a business or who are overseeing the early stages of business development (between one to two years). Such projects must promote a culture of women-led entrepreneurship and innovation that can be replicated in the community. Projects must also promote profitable businesses that gene...

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups.

Applicant type: Company.

Deadline: Jun 15, 2026.

The purpose of this Funding Opportunity Announcement is to invite proposals for funding from established organizations interested in providing innovative hands-on, in-person manufacturing training and technical assistance to eligible small manufacturing business concerns, under the U.S. Small Business Administration's Empower to Grow Program (formerly known as 7(j) Management and Technical Assistance Program).

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match.

Applicant type: Unknown.

Deadline is unknown; verify on the official source.

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Unknown.

Deadline: Jul 27, 2026.

NSF invests in scientific discoveries, technological breakthroughs, and transformative innovations that strengthen economic growth, enhance security, and improve the lives of Americans and people around the world. Our ability to support that mission requires a robust scientific and engineering (S&E) enterprise in the United States that allows scientists to innovate at the frontier. In addition to funding scientists, America needs next-generation scientific instrumentation that allows scientists to pursue new innovations. In many fields, it is critical that this new scientific instrumentation is developed in the United States. In support of this mission, NSF is initiating a pilot emphasis area for itsSBIR/STTR programs to invest in startups and small businesses that are specifically developing enabling technologies that include next-generation instrumentation, novel experimental platforms, and other scientific equipment to advance the frontiers of scientific discovery and strengthen the American scientific and engineering enterprise. This encompasses novel instrumentation necessary for the coming era of AI-driven discoveries. This pilot will prioritize investing in the necessary infrastructure to support entirely new fields of scientific discovery, making new technological breakthroughs and transformative applications possible. Through this approach, NSF will continue to lead in...

This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms.

Applicant type: Company.

Deadline: Jan 7, 2027.

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training.